TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare ConferenceBusiness Wire • 11/13/20
TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common StockBusiness Wire • 11/10/20
TherapeuticsMD's (TXMD) CEO Robert Finizio on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Analysts Estimate TherapeuticsMD (TXMD) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 11/02/20
Earnings Preview: TherapeuticsMD (TXMD) Q3 Earnings Expected to DeclineZacks Investment Research • 10/28/20
TherapeuticsMD Supports the Importance of Empowering Women to Make Informed Choices about their Sexual and Reproductive HealthBusiness Wire • 10/09/20
Implied Volatility Surging for TherapeuticsMD (TXMD) Stock OptionsZacks Investment Research • 10/07/20
TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor ConferencesBusiness Wire • 09/10/20
TherapeuticsMD: Remaining Bullish On This Reopening Play In The Biotech SectorSeeking Alpha • 08/30/20
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/08/20
Will TherapeuticsMD (TXMD) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/28/20